{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:37:05Z","timestamp":1787009825593,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To provide an updated overview of hemostatic disturbances and anticoagulation management during extracorporeal membrane oxygenation (ECMO), emphasizing the mechanisms underlying the dual risk of bleeding and thrombosis, current therapeutic strategies, and future perspectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Bleeding and thrombotic events remain the most frequent and life-threatening complications of ECMO, occurring in up to 50% of patients. Advances in mechanistic understanding have highlighted the roles of platelet activation and dysfunction, acquired von Willebrand syndrome, fibrinolytic imbalance, and hemolysis-induced endothelial injury. While unfractionated heparin remains the mainstay of anticoagulation, direct thrombin inhibitors such as bivalirudin have emerged as potential alternatives with comparable safety and efficacy. Viscoelastic testing, platelet function assays, and anti-Xa monitoring are increasingly integrated into clinical practice to refine anticoagulation titration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Hemostatic disturbances during ECMO reflect a complex interplay between patient severity, circuit-related shear stress, and systemic anticoagulation. Understanding these mechanisms is key to preventing both bleeding and thrombosis. Standardization of monitoring and the development of personalized, physiology-based anticoagulation protocols, supported by emerging technologies and more biocompatible circuits, represent the next step toward improving outcomes in ECMO-supported patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aco.0000000000001603","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:00:23Z","timestamp":1765551623000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Anticoagulation and hemostasis in the extracorporeal membrane oxygenation patient"],"prefix":"10.1097","volume":"39","author":[{"given":"Ouriel","family":"Saura","sequence":"first","affiliation":[{"name":"Institute of Cardiometabolism and Nutrition, Sorbonne Universit\u00e9, INSERM, UMRS_1166-ICAN"},{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, Institut de Cardiologie, H\u00f4pital Piti\u00e9\u2013Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Levy","sequence":"additional","affiliation":[{"name":"Institute of Cardiometabolism and Nutrition, Sorbonne Universit\u00e9, INSERM, UMRS_1166-ICAN"},{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, Institut de Cardiologie, H\u00f4pital Piti\u00e9\u2013Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Institute of Cardiometabolism and Nutrition, Sorbonne Universit\u00e9, INSERM, UMRS_1166-ICAN"},{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, Institut de Cardiologie, H\u00f4pital Piti\u00e9\u2013Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"R1-20260213","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2019.9302","article-title":"Extracorporeal life support for adults with respiratory failure and related indications: a review.","volume":"322","author":"Brodie","year":"2019","journal-title":"JAMA"},{"key":"R2-20260213","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00134-024-07356-0","article-title":"What\u2019s new in VA-ECMO for acute myocardial infarction-related cardiogenic shock.","volume":"50","author":"Combes","year":"2024","journal-title":"Intensive Care Med"},{"key":"R3-20260213","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","article-title":"Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis.","volume":"48","author":"Nunez","year":"2022","journal-title":"Intensive Care Med"},{"key":"R4-20260213","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MOP.0000000000001247","article-title":"Anticoagulation and hemostasis on extracorporeal membrane oxygenation.","volume":"35","author":"Carmona","year":"2023","journal-title":"Curr Opin Pediatr"},{"key":"R5-20260213","first-page":"3496","article-title":"Extracorporeal membrane oxygenation (ECMO)-associated coagulopathy in adults.","volume":"13","author":"Frantzeskaki","year":"2023","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"R6-20260213","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/phar.2859","article-title":"Anticoagulation strategies in patients with extracorporeal membrane oxygenation: a network meta\u2010analysis and systematic review.","volume":"43","author":"Chen","year":"2023","journal-title":"Pharmacotherapy"},{"key":"R7-20260213","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO adult and pediatric anticoagulation guidelines.","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J"},{"key":"R8-20260213","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MAT.0000000000001510","article-title":"ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients.","volume":"67","author":"Lorusso","year":"2021","journal-title":"ASAIO J"},{"key":"R9-20260213","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1097\/CCM.0000000000005466","article-title":"Longitudinal trends in bleeding complications on extracorporeal life support over the past two decades\u2014Extracorporeal Life Support Organization registry analysis.","volume":"50","author":"Willers","year":"2022","journal-title":"Crit Care Med"},{"key":"R10-20260213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13054-023-04612-5","article-title":"The interaction of thrombocytopenia, hemorrhage, and platelet transfusion in venoarterial extracorporeal membrane oxygenation: a multicenter observational study.","volume":"27","author":"Raasveld","year":"2023","journal-title":"Crit Care"},{"key":"R11-20260213","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.athoracsur.2020.02.012","article-title":"Risk factors of bleeding in patients undergoing venoarterial extracorporeal membrane oxygenation.","volume":"111","author":"Ellouze","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"R12-20260213","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00134-016-4318-3","article-title":"Brain injury during venovenous extracorporeal membrane oxygenation.","volume":"42","author":"Luyt","year":"2016","journal-title":"Intensive Care Med"},{"key":"R13-20260213","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/cc12681","article-title":"Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study.","volume":"17","author":"Aubron","year":"2013","journal-title":"Crit Care"},{"key":"R14-20260213","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/CCM.0000000000004762","article-title":"Timing, outcome, and risk factors of intracranial hemorrhage in acute respiratory distress syndrome patients during venovenous extracorporeal membrane oxygenation.","volume":"49","author":"Hunsicker","year":"2021","journal-title":"Crit Care Med"},{"key":"R15-20260213","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11239-023-02909-4","article-title":"Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry.","volume":"57","author":"Kohs","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"R16-20260213","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjh.17870","article-title":"Impact of major bleeding and thrombosis on 180\u2010day survival in patients with severe COVID\u201019 supported with veno\u2010venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study.","volume":"196","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"key":"R17-20260213","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/MAT.0000000000001694","article-title":"Incidence of venous thromboembolism in adults receiving extracorporeal membrane oxygenation: a systematic review.","volume":"68","author":"Iannattone","year":"2022","journal-title":"ASAIO J"},{"key":"R18-20260213","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/CCM.0000000000006476","article-title":"Vascular complications after venoarterial extracorporeal membrane oxygenation support: a CT study.","volume":"53","author":"Djavidi","year":"2025","journal-title":"Crit Care Med"},{"key":"R19-20260213","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1016\/j.jtha.2025.08.010","article-title":"Association of coagulation dysfunction with thrombosis, bleeding, and mortality in patients supported by veno\u2013venous extracorporeal membrane oxygenation for viral pneumonia.","volume":"23","author":"Arachchillage","year":"2025","journal-title":"J Thromb Haemost"},{"key":"R20-20260213","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fmed.2018.00352","article-title":"Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components.","volume":"5","author":"Doyle","year":"2018","journal-title":"Front Med"},{"key":"R21-20260213","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V55.1.156.156","article-title":"Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces.","volume":"55","author":"Vroman","year":"1980","journal-title":"Blood"},{"key":"R22-20260213","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0142-9612(96)80004-4","article-title":"Proteins involved in the Vroman effect during exposure of human blood plasma to glass and polyethylene.","volume":"17","author":"Turbill","year":"1996","journal-title":"Biomaterials"},{"key":"R23-20260213","doi-asserted-by":"crossref","first-page":"14557","DOI":"10.1038\/s41598-023-41773-3","article-title":"Bleeding patients on extracorporeal membrane oxygenation have reduced platelet aggregation and plasma fibrinogen: a longitudinal observational study.","volume":"13","author":"Hvas","year":"2023","journal-title":"Sci Rep"},{"key":"R24-20260213","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/CCM.0000000000001482","article-title":"Hemostatic changes during extracorporeal membrane oxygenation: a prospective randomized clinical trial comparing three different extracorporeal membrane oxygenation systems.","volume":"44","author":"Malfertheiner","year":"2016","journal-title":"Crit Care Med"},{"key":"R25-20260213","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1055\/a-1529-2257","article-title":"Extracorporeal membrane oxygenation induces early alterations in coagulation and fibrinolysis profiles in COVID-19 patients with acute respiratory distress syndrome.","volume":"121","author":"H\u00e9kimian","year":"2021","journal-title":"Thromb Haemost"},{"key":"R26-20260213","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1016\/j.jtha.2023.06.034","article-title":"Thombosis, major bleeding, and survival in COVID-19 supported by veno-venous extracorporeal membrane oxygenation in the first vs second wave: a multicenter observational study in the United Kingdom.","volume":"21","author":"Arachchillage","year":"2023","journal-title":"J Thromb Haemost"},{"key":"R27-20260213","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcrc.2014.10.002","article-title":"Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.","volume":"30","author":"Frantzeskaki","year":"2015","journal-title":"J Crit Care"},{"key":"R28-20260213","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0022-3476(96)80133-8","article-title":"Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation.","volume":"128","author":"Fortenberry","year":"1996","journal-title":"J Pediatr"},{"key":"R29-20260213","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1038\/s41598-021-87026-z","article-title":"Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.","volume":"11","author":"Cartwright","year":"2021","journal-title":"Sci Rep"},{"key":"R30-20260213","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2018.03.013","article-title":"Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: rapid onset and fast recovery.","volume":"37","author":"Kalbhenn","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R31-20260213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-025-05569-3","article-title":"Incidence, kinetics, and clinical impact of thrombocytopenia in venovenous ECMO: insights from the multicenter observational PROTECMO study.","volume":"29","author":"Buchtele","year":"2025","journal-title":"Crit Care"},{"key":"R32-20260213","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/CCM.0000000000005467","article-title":"Acquired von Willebrand syndrome and desmopressin resistance during venovenous extracorporeal membrane oxygenation in patients with COVID-19: a prospective observational study.","volume":"50","author":"Kalbhenn","year":"2022","journal-title":"Crit Care Med"},{"key":"R33-20260213","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.jtha.2023.08.007","article-title":"Acquired von Willebrand disease in children undergoing extracorporeal membrane oxygenation: a prospective observational study.","volume":"21","author":"Drop","year":"2023","journal-title":"J Thromb Haemost"},{"key":"R34-20260213","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/SHK.0000000000002632","article-title":"Von Willebrand factor in ecmo: a dynamic modulator of hemorrhage and thrombosis.","volume":"64","author":"Liu","year":"2025","journal-title":"Shock"},{"key":"R35-20260213","article-title":"Shear-induced acquired von Willebrand syndrome: an accomplice of bleeding events in adults on extracorporeal membrane oxygenation support.","volume":"10","author":"Wang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R36-20260213","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.jacc.2018.02.075","article-title":"Arterial pulsatility and circulating von Willebrand factor in patients on mechanical circulatory support.","volume":"71","author":"Vincent","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R37-20260213","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3390\/jcm9082361","article-title":"Platelet functions during extracorporeal membrane oxygenation. Platelet\u2013leukocyte aggregates analyzed by flow cytometry as a promising tool to monitor platelet activation.","volume":"9","author":"Mansour","year":"2020","journal-title":"J Clin Med"},{"key":"R38-20260213","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1213\/ANE.0000000000000554","article-title":"Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.","volume":"120","author":"Tauber","year":"2015","journal-title":"Anesth Analg"},{"key":"R39-20260213","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/CIRCRESAHA.123.322752","article-title":"Shear force-induced platelet clearance is a new mechanism of thrombocytopenia.","volume":"133","author":"Rauch","year":"2023","journal-title":"Circ Res"},{"key":"R40-20260213","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2022.02.011","article-title":"Coagulation activation during extracorporeal membrane oxygenation (ECMO).","volume":"211","author":"Chandler","year":"2022","journal-title":"Thromb Res"},{"key":"R41-20260213","doi-asserted-by":"crossref","first-page":"109358","DOI":"10.1016\/j.thromres.2025.109358","article-title":"Exploring the role of inflammation and proinflammatory proteins in coagulopathy during venovenous extracorporeal membrane oxygenation.","volume":"251","author":"Wang","year":"2025","journal-title":"Thromb Res"},{"key":"R42-20260213","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/ALN.0000000000004980","article-title":"Fibrinolysis as a causative mechanism for bleeding complications on extracorporeal membrane oxygenation: a pilot observational prospective study.","volume":"141","author":"Helms","year":"2024","journal-title":"Anesthesiology"},{"key":"R43-20260213","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/ATVBAHA.123.318780","article-title":"Basic mechanisms of hemolysis-associated thrombo-inflammation and immune dysregulation.","volume":"43","author":"Dimitrov","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R44-20260213","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.202305-0896OC","article-title":"Anticoagulation and bleeding during veno-venous extracorporeal membrane oxygenation: insights from the ProtecMo study.","volume":"209","author":"Martucci","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R45-20260213","doi-asserted-by":"crossref","first-page":"10600280251371081","DOI":"10.1177\/10600280251371081","article-title":"Retrospective, single-center cohort study of bivalirudin compared to unfractionated heparin in patients receiving extracorporeal membrane oxygenation.","author":"Lofy","year":"2025","journal-title":"Ann Pharmacother"},{"key":"R46-20260213","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hrtlng.2023.05.003","article-title":"Comparison of anticoagulation monitoring strategies for adults supported on extracorporeal membrane oxygenation: a systematic review.","volume":"61","author":"Sun","year":"2023","journal-title":"Heart Lung"},{"key":"R47-20260213","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.3390\/jcm11226821","article-title":"Anticoagulation strategies during extracorporeal membrane oxygenation: a narrative review.","volume":"11","author":"Rajsic","year":"2022","journal-title":"J Clin Med"},{"key":"R48-20260213","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/a-1508-8230","article-title":"Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation.","volume":"122","author":"Kanji","year":"2022","journal-title":"Thromb Haemost"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:01:14Z","timestamp":1770984074000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001603","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}